Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats

Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats

Introduction: There are several pathologic mechanisms involved in diabetic nephropathy, but the role of oxidative stress seems to be one of the most important. Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a relatively new class of antidiabetic drugs that might also have some other effects i...

Full description

Bibliographic Details
Main Authors: Habib Yaribeygi, Mohammad Amin Hemmati, Fatemeh Nasimi, Mina Maleki, Tannaz Jamialahmadi, Ivan Reiner, Željko Reiner, Amirhossein Sahebkar
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Journal of Clinical Medicine
Subjects:
diabetes mellitus
diabetic nephropathy
oxidative stress
SGLT2 inhibitor
empagliflozin
malondialdehyde
Online Access:https://www.mdpi.com/2077-0383/12/11/3815

Internet

https://www.mdpi.com/2077-0383/12/11/3815

Similar Items